Interaction of natural killer cells with neutrophils exerts a significant antitumor immunity in hematopoietic stem cell transplantation recipients

Cancer Medicine

Volumn 5, Issue 1, 2016, Pages 49-60

  Ueda, Ryosuke ^a   Narumi, Kenta ^a   Hashimoto, Hisayoshi ^a   Miyakawa, Reina ^a   Okusaka, Takuji ^b   Aoki, Kazunori ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Antitumor immunity; Autologous hematopoietic stem cell transplantation; Homeostatic proliferation; Neutrophil; NK cell

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL INTERACTION; CELL SURVIVAL; COLON CANCER; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IN VIVO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MOUSE; NATURAL KILLER CELL; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; THERAPY EFFECT; TUMOR IMMUNITY; ANIMAL; CELL COMMUNICATION; DISEASE MODEL; IMMUNOLOGY; LYMPHOCYTE DEPLETION; METABOLISM; NEOPLASMS; PATHOLOGY; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TUMOR CELL LINE;

ANIMALS; CELL COMMUNICATION; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MICE; NEOPLASMS; NEUTROPHIL INFILTRATION; NEUTROPHILS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 85006219533     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.550     Document Type: Article

References (33)

1. Cunningham, D., L. Paz-Ares, S. Milan, R. Powles, M. Nicolson, T. Hickish, et al. 1994. High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma. J. Clin. Oncol. 12:759-763.
2. Rappeport, J., M. Mihm, E. Reinherz, S. Lopansri, and R. Parkman . 1979. Acute graft-versus-host disease in recipients of bone-marrow transplants from identical twin donors. Lancet 2:717-720.
3. Otegbeye, F., R. P. Gale, and H. M. Lazarus . 2014. Autologous GVHD? Bone Marrow Transplant. 49:1349-1351.
4. Dummer, W., A. G. Niethammer, R. Baccala, B. R. Lawson, N. Wagner, R. A. Reisfeld, et al. 2002. T cell homeostatic proliferation elicits effective antitumor autoimmunity. J. Clin. Invest. 110:185-192.
5. Li, H. W., and M. Sykes . 2012. Emerging concepts in haematopoietic cell transplantation. Nat. Rev. Immunol. 12:403-416.
6. Borrello, I., E. M. Sotomayor, F. M. Rattis, S. K. Cooke, L. Gu, and H. I. Levitsky . 2000. Sustaining the graft-versus-tumor effect through posttransplant immunization with granulocyte-macrophage colony-stimulating factor (GM-CSF)-producing tumor vaccines. Blood 95:3011-3019.
7. Hu, H. M., C. H. Poehlein, W. J. Urba, and B. A. Fox . 2002. Development of antitumor immune responses in reconstituted lymphopenic hosts. Cancer Res. 62:3914-3919.
8. Baccala, R., R. Gonzalez-Quintial, W. Dummer, and A. N. Theofilopoulos . 2005. Tumor immunity via homeostatic T cell proliferation: mechanistic aspects and clinical perspectives. Springer Semin. Immunopathol. 27:75-85.
9. Restifo, N. P., M. E. Dudley, and S. A. Rosenberg . 2012. Adoptive immunotherapy for cancer: harnessing the T cell response. Nat. Rev. Immunol. 12:269-281.
10. Narumi, K., T. Udagawa, A. Kondoh, A. Kobayashi, H. Hara, Y. Ikarashi, et al. 2012. In vivo delivery of interferon-alpha gene enhances tumor immunity and suppresses immunotolerance in reconstituted lymphopenic hosts. Gene Ther. 19:34-48.
11. Udagawa, T., K. Narumi, K. Suzuki, K. Aida, R. Miyakawa, Y. Ikarashi, et al. 2013. Vascular endothelial growth factor-D-mediated blockade of regulatory T cells within tumors is induced by hematopoietic stem cell transplantation. J. Immunol. 191:3440-3452.
12. Murphy, W. J., P. Parham, and J. S. Miller . 2012. NK cells-from bench to clinic. Biol. Blood Marrow Transplant. 18:S2-S7.
13. Pical-Izard, C., R. Crocchiolo, S. Granjeaud, E. Kochbati, S. Just-Landi, C. Chabannon, et al. 2015. Reconstitution of natural killer cells in HLA-matched HSCT after reduced-intensity conditioning: impact on clinical outcome. Biol. Blood Marrow Transplant. 21:429-439.
14. Moretta, L., F. Locatelli, D. Pende, E. Marcenaro, M. C. Mingari, and A. Moretta . 2011. Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation. Blood 117:764-771.
15. Prlic, M., B. R. Blazar, M. A. Farrar, and S. C. Jameson . 2003. In vivo survival and homeostatic proliferation of natural killer cells. J. Exp. Med. 197:967-976.
16. Bosch, M., F. M. Khan, and J. Storek . 2012. Immune reconstitution after hematopoietic cell transplantation. Curr. Opin. Hematol. 19:324-335.
17. Nauseef, W. M., and N. Borregaard . 2014. Neutrophils at work. Nat. Immunol. 15:602-611.
18. Costantini, C., and M. A. Cassatella . 2011. The defensive alliance between neutrophils and NK cells as a novel arm of innate immunity. J. Leukoc. Biol. 89:221-233.
19. Mocsai, A. 2013. Diverse novel functions of neutrophils in immunity, inflammation, and beyond. J. Exp. Med. 210:1283-1299.
20. Jaeger, B. N., J. Donadieu, C. Cognet, C. Bernat, D. Ordonez-Rueda, V. Barlogis, et al. 2012. Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis. J. Exp. Med. 209:565-580.
21. Daley, J. M., A. A. Thomay, M. D. Connolly, J. S. Reichner, and J. E. Albina . 2008. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J. Leukoc. Biol. 83:64-70.
22. Sun, J. C., J. N. Beilke, N. A. Bezman, and L. L. Lanier . 2011. Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection. J. Exp. Med. 208:357-368.
23. Chiossone, L., J. Chaix, N. Fuseri, C. Roth, E. Vivier, and T. Walzer . 2009. Maturation of mouse NK cells is a 4-stage developmental program. Blood 113:5488-5496.
24. Hayakawa, Y., and M. J. Smyth . 2006. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J. Immunol. 176:1517-1524.
25. Vosshenrich, C. A., S. I. Samson-Villeger, and J. P. Di Santo . 2005. Distinguishing features of developing natural killer cells. Curr. Opin. Immunol. 17:151-158.
26. Gabrilovich, D. I., S. Ostrand-Rosenberg, and V. Bronte . 2012. Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 12:253-268.
27. Porrata, L. F., D. J. Inwards, S. M. Ansell, I. N. Micallef, P. B. Johnston, D. A. Gastineau, et al. 2008. Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: a prospective study. Biol. Blood Marrow Transplant. 14:807-816.
28. Nguyen, S., N. Dhedin, J. P. Vernant, M. Kuentz, A. Al Jijakli, N. Rouas-Freiss, et al. 2005. NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect. Blood 105:4135-4142.
29. Vago, L., B. Forno, M. P. Sormani, R. Crocchiolo, E. Zino, S. Di Terlizzi, et al. 2008. Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation. Blood 112:3488-3499.
30. Gill, S., A. E. Vasey, A. De Souza, J. Baker, A. T. Smith, H. E. Kohrt, et al. 2012. Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells. Blood 119:5758-5768.
31. Marcais, A., S. Viel, M. Grau, T. Henry, J. Marvel, and T. Walzer . 2013. Regulation of mouse NK cell development and function by cytokines. Front. Immunol. 4:450.
32. Sporri, R., N. Joller, H. Hilbi, and A. Oxenius . 2008. A novel role for neutrophils as critical activators of NK cells. J. Immunol. 181:7121-7130.
33. Narumi, K., R. Miyakawa, R. Ueda, H. Hashimoto, Y. Yamamoto, T. Yoshida, et al. 2015. Proinflammatory proteins S100A8/S100A9 activate NK cells via interaction with RAGE. J. Immunol. 194:5539-5548.